You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB1174 ORM2 and APOA2 serum levels can predict oa patient response to chondroitin sulfate/glucosamine hydrochloride: results from the moves study

Citation Tools

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Validation of outcome measures and biomarkers
AB1174 ORM2 and APOA2 serum levels can predict oa patient response to chondroitin sulfate/glucosamine hydrochloride: results from the moves study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Calamia V, Camacho-Encina M, González-Rodríguez L, et al
AB1174 ORM2 and APOA2 serum levels can predict oa patient response to chondroitin sulfate/glucosamine hydrochloride: results from the moves study
Annals of the Rheumatic Diseases 2017;76:1466-1467.